Nail Dystrophy

Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy
psoriasis Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment Danielle Rinck MDa, Elaine Siegfried MDb aBeth Israel Deaconess Medical Center, Boston, MA | bSaint Louis University School of Medicine, St. Louis, MO J Drugs Dermatol. 2022;21(8):897-899. doi:10.36849/JDD.6888   A previously healthy 3-year-old boy presented to our Pediatric Derm …
psoriasis
Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment
psoriasisPsoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children. INTRODUCTIO …
psoriasis
JDD August Issue Highlights | Special Focus: Psoriasis
psoriasisThe August issue of the Journal of Drugs in Dermatology (JDD) focuses on Psoriasis and features mix of original articles, editorials, and case reports. Among many of the topics explored in this issue are treatment of scalp psoriasis, nail psoriasis, respiratory tract infections in patients using biologics for hidradenitis suppurativa, classification of actinic keratosis, lichen planus pigmentosus …
psoriasis